SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; SPIRONOLACTONE) — FDA Approval ANDA086513 (MYLAN)
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; SPIRONOLACTONE) — FDA Approval ANDA086513 (MYLAN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; SPIRONOLACTONE; Application number: ANDA0
| Brand name | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
| Application number | ANDA086513 |
| Sponsor | MYLAN |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 19790803 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →